A NOVEL PROCESS FOR THE MANUFACTURING OF CRYSTALLINE FORM-II OF LAMIVUDINE.

Application 926/MUM/2001 published 2005-05-06, filed 2001-09-25
A process for the direct preparation of Lamivudine polymorph of Form II is disclosed. The process of the invention involves the direct preparation of Lamivudine polymorph of Form II from its salicylate salt thereby avoiding the formation or use of Form I. The process comprises suspending Lamivudine salicylate monohydrate in a solvent selected from the group consisting of aliphatic ketones, esters, either straight chain or branched chain ethers containing 1 … 8 carbon atoms, refluxing the mixture to at the reflux temperature of the solvent, adding on organic base at said reflux temperature, cooling it and filtering out the product Form II of Lamivudine. The process is economical, and is capable of operation on a commercial scale with minimum contamination with Form I polymorph of Lamivudine. The yield obtained is about 93% with high HPCL purity above 99.5% which is isolated from the aqueous medium. ( Figure: NIL ) Total Pages : 16.

Applicant

CADILA HEALTHCARE LIMITED
ZYDUS TOWER, SATELLITE CROSS ROADS, AHMEDABAD 380 015, GUJARAT, INDIA.

Inventor

s: 1. SHAH CHIRAG SURENDRABHAI 2. SORATHIA SURESH DEVJIBHAI 3. AGARWAL VIRENDRA KUMAR 4. RAMAKRISHNA NIROGI VENKATA SATYA 5. PANDITA KANWAL 6. PATEL PANKAJ RAMANBHAI Filed U/S 5(2) before the Patents (Amendment) Ordinance,2004 : NO

International Info

Classification: A 61 P 31/12, A 61 P 31/14, C 07 D 411/04